REG - Cirata PLC - $3.1m Multiyear Contract with leading US Insurer

CirataAnnouncement

Today 07:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251013:nRSM0038Da&default-theme=true

RNS Number : 0038D  Cirata PLC  13 October 2025

13 October 2025

Cirata plc

("Cirata" or the "Company")

$3.1m Multiyear Data Integration Contract with leading US Insurer

The largest direct contract in Company's history

Cirata plc (LSE: CRTA) is pleased to announce a $3.1m, 3-year Data Integration
(DI) software contract with a leading US insurer. This growth contract
represents the largest direct contract in Cirata's history and signifies a
transition from a 1-year legacy Fusion product agreement to a new longer term
3-year partnership and relationship.

 

The new contract encompasses the deployment of Data Migrator (DM), with a
focus on disaster recovery applications.

 

Cirata expects to provide a Q3 FY25 Trading Update on 16 October 2025.

 

This announcement contains inside information under the UK Market Abuse
Regulation. The person responsible for arranging the release of this
announcement on behalf of Cirata plc is Stephen Kelly, Chief Executive
Officer.

 

For further information, please contact:

 Cirata                                     Via FTI Consulting
 Stephen Kelly, Chief Executive Officer
 Ricardo Moura, Chief Financial Officer
 Dan Hayes, Investor Relations

 FTI Consulting                             +44 (0) 20 3727 1137
 Matt Dixon / Kwaku Aning / Usama Ali

 Stifel (Nomad and Joint Broker)            +44 (0) 20 7710 7600
 Fred Walsh / Brough Ransom / Ben Good

 Panmure Liberum (Joint Broker)             +44 (0) 20 3100 2000
 Max Jones / Rupert Dearden / John More

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CNTMBBMTMTMBBFA



            Copyright 2019 Regulatory News Service, all rights reserved